| CHEMICAL INDUSTRY JOURNAL |
| big interview |
Seamus White, Bachem Business Development Manager
Oligonucleotides: the journey so far For oligonucleotide api manufacturers, putting in place capacity and sustainability solutions will be essential to meet increased demand. The molecules will be needed in ever greater quantities to fulfil rising needs as new uses are found in research, diagnosis and drug development. Seamus White, Bachem business development manager, tells Chemical Industry Journal how oligonucleotide therapeutics could simplify the work of pharma and biotech companies.
30
